Laporan Laba Rugi VTRLY - TTM - Vitrolife AB (publ) - Depositary Receipt (Common Stock)

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Vitrolife AB (publ) - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	1,273	1,246	1,291	1,464	1,549	1,681	2,054	2,501	2,893	3,234	3,336	3,412	3,462	3,512	3,499	3,535	3,555	3,609	3,610	3,541
Change (%)		-2.13	3.62	13.39	5.87	8.49	22.19	21.76	15.67	11.79	3.15	2.28	1.47	1.44	-0.37	1.03	0.57	1.52	0.03	-1.91
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	504	478	482	529	551	635	836	1,050	1,277	1,454	1,490	1,531	1,536	1,534	1,526	1,503	1,487	1,470	1,468	1,457
Change (%)		-5.24	0.78	9.76	4.14	15.34	31.65	25.60	21.62	13.86	2.48	2.75	0.33	-0.13	-0.52	-1.51	-1.06	-1.14	-0.14	-0.75
% of Revenue	39.63	38.37	37.32	36.12	35.53	37.78	40.70	41.98	44.14	44.96	44.66	44.87	44.37	43.68	43.61	42.52	41.83	40.73	40.66	41.15

Gross Operating Profit	768	768	809	935	999	1,046	1,218	1,451	1,616	1,780	1,846	1,881	1,926	1,978	1,973	2,032	2,068	2,139	2,142	2,084
Change (%)		-0.09	5.39	15.55	6.84	4.72	16.44	19.13	11.37	10.15	3.71	1.90	2.39	2.70	-0.25	2.99	1.77	3.43	0.14	-2.71
% of Revenue	60.37	61.63	62.68	63.88	64.47	62.22	59.30	58.02	55.86	55.04	55.34	55.13	55.63	56.32	56.39	57.48	58.17	59.27	59.34	58.85

SG&A	324	311	308	333	353	503	656	811	961	1,002	1,048	1,076	1,092	1,117	1,118	1,150	1,181	1,232	1,243	1,262
Change (%)		-3.96	-1.20	8.29	5.93	42.54	30.42	23.63	18.50	4.27	4.59	2.67	1.49	2.29	0.09	2.86	2.70	4.32	0.89	1.53
% of Revenue	25.47	25.00	23.83	22.76	22.78	29.92	31.94	32.43	33.22	30.98	31.41	31.54	31.54	31.81	31.95	32.53	33.22	34.14	34.43	35.64

R&D	97	92	91	94	103	114	133	151	157	143	133	124	122	127	126	118	117	117	110	113
Change (%)		-4.95	-0.71	3.01	9.81	10.62	16.67	13.53	3.97	-8.92	-6.99	-6.77	-1.61	4.10	-0.79	-6.35	-0.85	0.00	-5.98	2.73
% of Revenue	7.59	7.37	7.06	6.41	6.65	6.78	6.48	6.04	5.43	4.42	3.99	3.63	3.52	3.62	3.60	3.34	3.29	3.24	3.05	3.19

OpEx	919	878	875	953	1,008	1,252	1,633	2,017	2,375	2,587	2,664	2,729	2,776	2,774	2,753	2,758	2,783	2,818	2,836	2,846
Change (%)		-4.38	-0.35	8.82	5.81	24.21	30.43	23.52	17.75	8.93	2.98	2.44	1.72	-0.07	-0.76	0.18	0.91	1.26	0.64	0.35
% of Revenue	72.19	70.53	67.82	65.09	65.06	74.48	79.50	80.65	82.09	79.99	79.86	79.98	80.18	78.99	78.68	78.02	78.28	78.08	78.56	80.37

Operating Income	354	367	415	511	541	429	421	484	518	647	672	683	686	738	746	777	772	791	774	695
Change (%)		3.73	13.13	23.02	5.97	-20.76	-1.86	14.96	7.02	24.90	3.86	1.64	0.44	7.58	1.08	4.16	-0.64	2.46	-2.15	-10.21
% of Revenue	27.81	29.47	32.18	34.91	34.94	25.52	20.50	19.35	17.91	20.01	20.14	20.02	19.82	21.01	21.32	21.98	21.72	21.92	21.44	19.63

Interest Expense	-2	-2	-2	-2	-2	-10	-34	-39	-66	-44	-42	-18	-98	-94	-99	-94	-53	-98	-92	-98
Change (%)		-9.51	-0.00	-0.00	-0.00	379.62	240.00	14.71	69.23	-33.33	-4.55	-57.14	444.44	-4.08	5.32	-5.05	-43.62	84.91	-6.12	6.52
% of Revenue	-0.18	-0.17	-0.16	-0.14	-0.13	-0.59	-1.66	-1.56	-2.28	-1.36	-1.26	-0.53	-2.83	-2.68	-2.83	-2.66	-1.49	-2.72	-2.55	-2.77

Net Income	276	287	325	399	415	341	305	349	353	394	412	388	402	-3,851	-3,836	-3,799	-3,805	513	498	455
Change (%)		4.02	13.30	22.88	3.97	-17.88	-10.56	14.43	1.15	11.61	4.57	-5.83	3.61	-1,057.96	-0.39	-0.96	0.16	-113.48	-2.92	-8.63
% of Revenue	21.67	23.03	25.18	27.29	26.80	20.29	14.85	13.95	12.20	12.18	12.35	11.37	11.61	-109.65	-109.63	-107.47	-107.03	14.21	13.80	12.85

Source: Capital IQ

Vitrolife AB (publ) - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)